Startup based in Japan, most recent round Series C.
Based in Japan, EditForce is a startup. Its most recent tracked round is Series C.
EditForce develops proprietary RNA/DNA editing technologies based on pentatricopeptide repeat (PPR) proteins, applying these innovations to drug discovery and aiming to create new modalities for treating various diseases as well as applications in chemicals and agriculture.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.